Back
HFA Premium Access

Mid-term outcomes in heart failure patients treated with non-vitamin K antagonist oral anticoagulants. A real world study.

Session: Poster Session 3 - Atrial Fibrillation - Epidemiology, Prognosis, Outcome
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor C. Goena Vives (Donostia, ES)
Event: Heart Failure 2018

Congress Presentation

About the speaker

Doctor Cristina Goena Vives

Donostia University Hospital, Donostia (Spain)
3 presentations
0 follower

4 more presentations in this session

Clinical characteristics of patients with heart failure with mid-range ejection fraction and atrial fibrillation

Speaker: Associate Professor G. Giannakoulas (Thessaloniki, GR)

Access
Abstract
Slides
Thumbnail

Development of persistent atrial fibrillation over 18 months in the RESPIRE study in unselected pacemaker patients with or without severe sleep apnoea

Speaker: Doctor L. Jesel (Strasbourg, FR)

Access
Abstract
Slides
Thumbnail

Holter monitoring value in cardioembolic stroke: a follow up study

Speaker: Doctor H. Nascimento (Porto, PT)

Access
Abstract
Thumbnail

Development of significant atrial fibrillation over 18 months in the RESPIRE study in unselected pacemaker patients with or without severe sleep apnoea

Speaker: Doctor P. Marques (Lisboa, PT)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster Session 3 - Atrial Fibrillation - Epidemiology, Prognosis, Outcome

Speakers: Doctor C. Goena Vives, Associate Professor G. Giannakoulas, Doctor L. Jesel, Doctor H. Nascimento, Doctor P. Marques
Access
Thumbnail

About the event

Image

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb